News AZ's Tagrisso brings 'unprecedented' benefit in untreated NS... Drug could become standard of care, says AZ
News Pfizer's lung cancer drug dacomitinib gets fast US review Drug beat AZ's Iressa in head-to-head trial, concerns over side-effects
News New data boosts Roche lung cancer combo More positive results from Tecentriq, Avastin and chemo combo
News AbbVie's shares tank after cancer hopeful's phase 2 setback Decision wipes $24 billion from share price
News Roche's Tecentriq halts disease in squamous lung cancer Roche’s cancer immunotherapy Tecentriq has produced strong results which could give it the lead in a key lung cancer indication.
News Merck & Co boosted by Keytruda first-line lung cancer trial KEYNOTE-189 results could see US Merck tighten its grip in cancer immunotherapy.
News ADARx, Trex, and Retension take aim at IPOs The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
